Aeterna Zentaris (AEZS), Specialised Therapeutics Enter Zoptrex Licensing Agreement in Australia, New Zealand
Tweet Send to a Friend
Aeterna Zentaris Inc. (Nasdaq: AEZS) and Specialised Therapeutics Asia announced the signing of an exclusive license agreement for the Company’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
